Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-08-24 16:02:48 ET · period of report 2026-08-22 · accession 0000097745-26-000153 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 16:02 | 2026-08-22 | TMO | Meyer James | CFO, Sr. VP | F - Tax | $629.27 | -30.95 | 5,830 | -0.5% | -$19.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-22 | F | D | 30.95 | $629.27 | 5,830.04 | D | — | — | (F1) Includes 19.519 shares acquired under the Issuers employees stock purchase plan on May 15, 2026. |